resveratrol has been researched along with celecoxib in 15 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (33.33) | 29.6817 |
| 2010's | 8 (53.33) | 24.3611 |
| 2020's | 2 (13.33) | 2.80 |
| Authors | Studies |
|---|---|
| Chiou, WF; Lin, LC; Lin, SJ; Shiao, YJ; Teng, CM; Tsai, WJ; Wu, TS; Yang, LM; Yang, TH | 1 |
| Brunhofer, G; Erker, T; Handler, N; Jaeger, W; Leisser, K; Parth, S; Studenik, C | 1 |
| Chiou, WF; Lin, SJ; Tsai, WJ; Yang, LM; Yang, TH | 1 |
| Artursson, P; Bergström, CA; Hoogstraate, J; Matsson, P; Norinder, U; Pedersen, JM | 1 |
| Cao, H; Chen, YG; Choi, Y; Fong, HH; Huang, R; Jermihov, KC; Kondratyuk, TP; Liu, Y; Marler, LE; Mesecar, AD; Pezzuto, JM; Qiu, X; Sturdy, M; van Breemen, RB; Wang, LQ; Yang, JH; Yu, R; Zhang, HJ | 1 |
| Chen, LZ; Jiao, MM; Liu, XH; Ruan, BF; Shi, JB; Tan, Y; Yao, L | 1 |
| Kishore, N; Kumar, P; Shanker, K; Verma, AK | 1 |
| Bai, XQ; Cui, MY; Li, CS; Liang, CW; Song, ZW; Wang, HY; Zhang, TY; Zheng, XJ | 1 |
| Alonso-López, R; Asomoza-Espinosa, R; Castañeda-Hernández, G; Granados-Soto, V; Ortiz, MI; Torres-López, JE | 1 |
| Bojková, B; Ekmekcioglu, C; Fedoročko, P; Jäger, W; Jendželovský, R; Kajo, K; Kassayová, M; Kisková, T; Kokošová, N; Kubatka, P; Maier-Salamon, A; Mikeš, J; Orendáš, P; Papčová, Z; Rentsen, E; Svoboda, M; Thalhammer, T | 1 |
| Gueler, F; Jang, MS; Meschede, AK; Schebb, NH; Shushakova, N; Willenberg, I | 1 |
| Balbontín-Ayala, F; Cañigral, A; Carlos, Fd; Cobo, T; Fernández-González, FJ; Fernández-Vázquez, JP; Gonzalo-Orden, JM; Sánchez-Lasheras, F; Vega, JA | 1 |
| Schneider, G; Schneider, P | 1 |
| Xie, Y; Yao, Y | 1 |
| Abudukerimu, A; Bai, B; Li, R; Liang, M; Liu, Y; Sun, Y; Tian, T | 1 |
2 review(s) available for resveratrol and celecoxib
| Article | Year |
|---|---|
Human disorders associated with inflammation and the evolving role of natural products to overcome.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Rheumatoid; Biological Products; Cardiovascular Diseases; Humans; Inflammation; Neoplasms; Skin Diseases | 2019 |
Experimental evidence of pharmacological management of anchorage in Orthodontics: A systematic review.
Topics: Acetylcysteine; Animals; Anti-Inflammatory Agents; Antioxidants; Bone Remodeling; Celecoxib; Clodronic Acid; Diclofenac; Diphosphonates; Humans; Imidazoles; Interferon-gamma; Isoxazoles; Lactones; Mice; Orthodontic Anchorage Procedures; Osteoclasts; Osteoprotegerin; Pamidronate; Rats; Resveratrol; Stilbenes; Sulfones; Tooth Mobility; Tooth Movement Techniques; Zoledronic Acid | 2015 |
13 other study(ies) available for resveratrol and celecoxib
| Article | Year |
|---|---|
Selective COX-2 inhibitors. Part 1: synthesis and biological evaluation of phenylazobenzenesulfonamides.
Topics: Azo Compounds; Blood Cells; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Humans; Molecular Structure; Structure-Activity Relationship; Sulfonamides | 2006 |
'Bridged' stilbene derivatives as selective cyclooxygenase-1 inhibitors.
Topics: Animals; Computer Simulation; Cyclooxygenase 1; Cyclooxygenase Inhibitors; Female; Guinea Pigs; Indenes; Male; Models, Molecular; Molecular Structure; Muscles; Naphthalenes; Resveratrol; Stilbenes; Structure-Activity Relationship | 2007 |
Selective COX-2 inhibitors. Part 2: synthesis and biological evaluation of 4-benzylideneamino- and 4-phenyliminomethyl-benzenesulfonamides.
Topics: Amination; Benzenesulfonamides; Benzylidene Compounds; Blood Platelets; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Humans; Imines; Methylation; Molecular Structure; Structure-Activity Relationship; Sulfonamides | 2008 |
Prediction and identification of drug interactions with the human ATP-binding cassette transporter multidrug-resistance associated protein 2 (MRP2; ABCC2).
Topics: Administration, Oral; Animals; Antineoplastic Agents; Antipsychotic Agents; Antiviral Agents; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Biological Transport; Cell Line; Computer Simulation; Cytochrome P-450 Enzyme System; Drug-Related Side Effects and Adverse Reactions; Estradiol; Humans; Insecta; Liver; Models, Molecular; Multidrug Resistance-Associated Protein 2; Multidrug Resistance-Associated Proteins; Neoplasm Proteins; Pharmaceutical Preparations; Pharmacology; Structure-Activity Relationship | 2008 |
Bioactive compounds from the fern Lepisorus contortus.
Topics: Animals; Anticarcinogenic Agents; Antineoplastic Agents; Aromatase Inhibitors; Caffeic Acids; Cyclooxygenase Inhibitors; Drug Screening Assays, Antitumor; Flavonoids; Glycosides; Humans; Inhibitory Concentration 50; Kaempferols; Mice; Molecular Structure; NF-kappa B; Nitric Oxide; Polypodiaceae; Quercetin; Tumor Necrosis Factor-alpha | 2011 |
Novel resveratrol-based flavonol derivatives: Synthesis and anti-inflammatory activity in vitro and in vivo.
Topics: Animals; Anti-Inflammatory Agents; Flavonoids; In Vitro Techniques; Inhibitory Concentration 50; Interleukin-6; Lipopolysaccharides; MAP Kinase Signaling System; Mice; Molecular Docking Simulation; NF-kappa B; Nitric Oxide; p38 Mitogen-Activated Protein Kinases; RAW 264.7 Cells; Resveratrol; Structure-Activity Relationship; Tumor Necrosis Factor-alpha | 2019 |
Synthesis, biological evaluation of benzothiazole derivatives bearing a 1,3,4-oxadiazole moiety as potential anti-oxidant and anti-inflammatory agents.
Topics: Animals; Anti-Inflammatory Agents; Benzothiazoles; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Free Radical Scavengers; Humans; Inflammation; Mice; Molecular Docking Simulation; Molecular Structure; Oxadiazoles; Structure-Activity Relationship | 2020 |
Comparison of the antinociceptive effect of celecoxib, diclofenac and resveratrol in the formalin test.
Topics: Analgesia; Animals; Anti-Inflammatory Agents, Non-Steroidal; Behavior, Animal; Celecoxib; Cyclooxygenase Inhibitors; Diclofenac; Female; Formaldehyde; Inflammation; Pain; Pyrazoles; Rats; Rats, Wistar; Resveratrol; Stilbenes; Sulfonamides | 2002 |
Resveratrol enhances the chemopreventive effect of celecoxib in chemically induced breast cancer in rats.
Topics: Animals; Anticarcinogenic Agents; Breast Neoplasms; Carcinogens; Celecoxib; Chemoprevention; Drug Synergism; Female; Humans; Mammary Neoplasms, Experimental; MCF-7 Cells; Methylnitrosourea; Pyrazoles; Rats; Rats, Sprague-Dawley; Resveratrol; Stilbenes; Sulfonamides | 2014 |
Food Polyphenols Fail to Cause a Biologically Relevant Reduction of COX-2 Activity.
Topics: Animals; Anti-Inflammatory Agents; Apigenin; Celecoxib; Cell Line, Tumor; Cells, Cultured; Cyclooxygenase 2; Enzyme Activation; Genistein; Humans; Indomethacin; Lipopolysaccharides; Male; Mice, Inbred C57BL; Monocytes; Polyphenols; Real-Time Polymerase Chain Reaction; Resveratrol; Stilbenes | 2015 |
A Computational Method for Unveiling the Target Promiscuity of Pharmacologically Active Compounds.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Biological Products; Celecoxib; Dose-Response Relationship, Drug; Drug Discovery; Humans; Phosphotransferases; Potassium Channel Blockers; Potassium Channels; Receptors, Glucocorticoid; Resveratrol; Software; Structure-Activity Relationship | 2017 |
Octenylsuccinate hydroxypropyl phytoglycogen, a dendrimer-like biopolymer, solubilizes poorly water-soluble active pharmaceutical ingredients.
Topics: Celecoxib; Dendrimers; Docetaxel; Fenofibrate; Glycogen; Griseofulvin; Pharmaceutic Aids; Resveratrol; Solubility; Solvents; Stilbenes; Succinates; Surface-Active Agents; Taxoids | 2018 |
Key Genes Associated with Pyroptosis in Gout and Construction of a miRNA-mRNA Regulatory Network.
Topics: Biomarkers; Celecoxib; Cyclooxygenase 2; Gene Expression Profiling; Gene Regulatory Networks; Gout; Humans; MicroRNAs; Molecular Docking Simulation; NLR Family, Pyrin Domain-Containing 3 Protein; Pyroptosis; Resveratrol; RNA, Messenger | 2022 |